D.Western Therapeutics InstituteD.Western Therapeutics Institute, Inc.4576東証グロース医薬品FY ending Dec 2025, consolidated, J-GAAP

D.Western Therapeutics Institute FY ending Dec 2024 results

D.Western Therapeutics Institute brought in ¥471.6M in revenue.

It lost about ¥257 for every ¥100 of sales at the operating level.

Revenue changed +10.1% from the prior year.

What changed from last year

FY ending Dec 2023 → FY ending Dec 2024

Revenue
+10.1%¥428.4M → ¥471.6M
Gross profit
+8.4%¥391.7M → ¥424.7M
Operating income
Loss-¥798.6M → -¥1.21B
Net income attributable to owners
Loss-¥812.4M → -¥1.29B
Operating cash flow
Loss-¥586.8M → -¥1.3B
Free cash flow
Loss-¥601.8M → -¥1.31B

Where the money goes

FY ending Dec 2023 → FY ending Dec 2024

Where ¥100 of sales goes

For every ¥100 D.Western Therapeutics Institute sells, how much goes where, and how much is kept.

FY ending Dec 2024
Cost of sales
¥10
SG&A
¥347
Operating loss
¥257
Net loss
¥274

Annual margin trends

Gross margin90.1%
FY ending Dec 2019: 95.5%95.5%FY ending Dec 2020: 95.2%95.2%FY ending Dec 2021: 95.1%95.1%FY ending Dec 2022: 93.8%93.8%FY ending Dec 2023: 91.4%91.4%FY ending Dec 2024: 90.1%90.1%FY19FY20FY21FY22FY23FY24
Operating margin-256.5%
FY ending Dec 2019: 20.2%20.2%FY ending Dec 2020: -74.7%-74.7%FY ending Dec 2021: -41.4%-41.4%FY ending Dec 2022: -68.3%-68.3%FY ending Dec 2023: -186.4%-186.4%FY ending Dec 2024: -256.5%-256.5%FY19FY20FY21FY22FY23FY24
Net margin-273.6%
FY ending Dec 2019: 22.9%22.9%FY ending Dec 2020: -77.6%-77.6%FY ending Dec 2021: -36.0%-36.0%FY ending Dec 2022: -95.9%-95.9%FY ending Dec 2023: -189.7%-189.7%FY ending Dec 2024: -273.6%-273.6%FY19FY20FY21FY22FY23FY24

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第28期(2025/01/01-2025/12/31)

    ID S100XS4G2026-03-23Open
  • EDINET (FSA Japan)

    有価証券報告書-第27期(2024/01/01-2024/12/31)

    ID S100VFSO2025-03-25Open
  • EDINET (FSA Japan)

    有価証券報告書-第26期(2023/01/01-2023/12/31)

    ID S100T4H92024-03-27Open
  • EDINET (FSA Japan)

    有価証券報告書-第25期(2022/01/01-2022/12/31)

    ID S100QHG22023-03-30Open
  • EDINET (FSA Japan)

    有価証券報告書-第24期(令和3年1月1日-令和3年12月31日)

    ID S100NR772022-03-29Open
  • EDINET (FSA Japan)

    有価証券報告書-第23期(令和2年1月1日-令和2年12月31日)

    ID S100KZGC2021-03-23Open

Extracted from XBRL: 44 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.